Clement Rioux
21Patents
5h-index
22Co-inventors
65Inventor score
Filing activity: Mar 15, 1996 → Apr 28, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7128918B1 | Streptococcus antigens | Human Necessities | 46 | Expired |
| US6100066A | Nucleic acid molecules encoding Haemophilus somnus proteins | Chemistry; Metallurgy | 11 | Expired |
| US6287574A | Proteinase K resistant surface protein of neisseria meningitidis | Human Necessities | 8 | Expired |
| US8309096B2 | Fusion protein | Chemistry; Metallurgy | 7 | Active |
| US7635482B2 | Streptococcus antigens | Human Necessities | 7 | Active |
| US6391316B1 | Vaccine compositions comprising Haemophilus somnus transferrin-binding proteins and methods of use | Human Necessities | 5 | Expired |
| US7273611B1 | Proteinase K resistant surface protein of neisseria meningitidis | Human Necessities | 4 | Expired |
| US7914794B2 | Group B streptococcus antigens | Human Necessities | 4 | Active |
| US7524509B2 | Proteosome-liposaccharide vaccine adjuvant | Chemistry; Metallurgy | 4 | Expired |
| US8211437B2 | Streptococcus antigens | Human Necessities | 2 | Active |
| US8173140B2 | Compositions and methods for activating innate and allergic immunity | Emerging Cross-Sectional Technologies | 2 | Expired |
| US6887686B2 | Cloning and expression of Haemophilus somnus transferrin-binding proteins | Human Necessities | 2 | Expired |
| US8226953B2 | Group B Streptococcus antigens | Human Necessities | 2 | Active |
| US8580262B2 | Group B Streptococcus antigens | Human Necessities | 1 | Active |
| US8709447B2 | Compositions and methods for activating innate and allergic immunity | Emerging Cross-Sectional Technologies | 1 | Active |
| US7749499B2 | Proteinase K resistant surface protein of Neisseria meningitidis | Human Necessities | 0 | Active |
| US8916514B2 | CASB7439 constructs | Human Necessities | 0 | Active |
| US7833717B2 | Proteinase K resistant surface protein of Neisseria meningitidis | Human Necessities | 0 | Active |
| US9433672B2 | Compositions and methods for activating innate and allergic immunity | Emerging Cross-Sectional Technologies | 0 | Active |
| US7786286B2 | Proteinase K resistant surface protein of Neisseria meningitidis | Human Necessities | 0 | Active |
| US7776335B2 | Proteinase K resistant surface protein of Neisseria meningitidis | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.